Zobrazeno 1 - 10
of 1 095
pro vyhledávání: '"M, Ginsberg"'
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Deep learning (DL) is a new technology that can assist prenatal ultrasound (US) in the detection of congenital heart disease (CHD) at the prenatal stage. Hence, an economic-epidemiologic evaluation (aka Cost-Utility Analysis) is r
Externí odkaz:
https://doaj.org/article/4fbfa3cec4f5435593365f3432a203a3
Autor:
Hari M. Bharadwaj, Alexandra R. Hustedt-Mai, Hannah M. Ginsberg, Kelsey M. Dougherty, Vijaya Prakash Krishnan Muthaiah, Anna Hagedorn, Jennifer M. Simpson, Michael G. Heinz
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-10 (2022)
Cross-species experiments on chinchillas and at-risk humans suggest cochlear synaptopathy from noise exposure and aging are widespread even among individuals with clinically normal hearing status.
Externí odkaz:
https://doaj.org/article/5d377a3cc6c349a3b205cbd1ca6c7d9e
Autor:
Chathika K Weerasuriya, Rebecca C Harris, C Finn McQuaid, Fiammetta Bozzani, Yunzhou Ruan, Renzhong Li, Tao Li, Kirankumar Rade, Raghuram Rao, Ann M Ginsberg, Gabriela B Gomez, Richard G White
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background Despite recent advances through the development pipeline, how novel tuberculosis (TB) vaccines might affect rifampicin-resistant and multidrug-resistant tuberculosis (RR/MDR-TB) is unknown. We investigated the epidemiologic impact
Externí odkaz:
https://doaj.org/article/9be4bc0c8463408a8ddd8d920e8aac53
Autor:
G. M. Ginsberg, D. Chemtob
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Between 2011 and 2015, Men who have sex with men (MSM) accounted for nearly half of new HIV cases among men in Israel. This study carries out a cost-utility analysis of PrEP (HIV Pre Exposure Prophylaxis), an antiretroviral medica
Externí odkaz:
https://doaj.org/article/a7bd395c40c24c728c9a29df35db07ef
Autor:
Ann M. Ginsberg
Publikováno v:
Expert Review of Vaccines, Vol 18, Iss 5, Pp 423-432 (2019)
Introduction: Tuberculosis (TB) is the leading infectious killer globally and new TB vaccines will be crucial to ending the epidemic. Since the introduction in 1921 of the only currently licensed TB vaccine, BCG, very few novel vaccine candidates or
Externí odkaz:
https://doaj.org/article/fc0a5ac078304ddb844ba766c99a5ff0
Publikováno v:
Israel Journal of Health Policy Research, Vol 7, Iss 1, Pp 1-14 (2018)
Abstract Background Passive immunization against RSV (Respiratory Syncytial Virus) is given in most western countries (including Israel) to infants of high risk groups such as premature babies, and infants with Congenital Heart Disease or Congenital
Externí odkaz:
https://doaj.org/article/fddb479782664654b56e3865df04f459
Autor:
Chathika K. Weerasuriya, Rebecca C. Harris, C. Finn McQuaid, Fiammetta Bozzani, Yunzhou Ruan, Renzhong Li, Tao Li, Kirankumar Rade, Raghuram Rao, Ann M. Ginsberg, Gabriela B. Gomez, Richard G. White
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/e4076f4ef7874fffbd143dbcb11ae8c2
Autor:
Sonali Kochhar, Draurio Barreira, Pauline Beattie, Marco Cavaleri, Alejandro Cravioto, Mike W. Frick, Ann M. Ginsberg, Ian Hudson, David C. Kaslow, Sherry Kurtz, Christian Lienhardt, Shabir A. Madhi, Christopher Morgan, Yalda Momeni, Deepali Patel, Helen Rees, Taryn Rogalski-Salter, Alexander Schmidt, Boitumelo Semete-Makokotlela, Gerald Voss, Richard G White, Matteo Zignol, Birgitte Giersing
Publikováno v:
Vaccine. 40:1681-1690
Autor:
Jeroen C. de Jonge, Diederik van de Beek, Patrick Lyden, Marian C. Brady, Philip M. Bath, H. Bart van der Worp, K.R. Lees, A. Alexandrov, E. Berge, E. Bluhmki, N. Bornstein, C. Chen, L. Claesson, S.M. Davis, G. Donnan, H.C. Diener, M. Fisher, M. Ginsberg, B. Gregson, J. Grotta, W. Hacke, M.G. Hennerici, M. Hommel, M. Kaste, J. Marler, K. Muir, N. Venketasubramanian, R. Sacco, A. Shuaib, P. Teal, N.G. Wahlgren, S. Warach, C. Weimar
Publikováno v:
Stroke, 53(1), 53-60. Lippincott Williams and Wilkins
Background and Purpose: The occurrence of pneumonia after stroke is associated with a higher risk of poor outcome or death. We assessed the temporal profile of pneumonia after stroke and its association with poor outcome at several time points to ide
Autor:
C Fordham von Reyn, Timothy Lahey, Robert D Arbeit, Bernard Landry, Leway Kailani, Lisa V Adams, Brenda C Haynes, Todd Mackenzie, Wendy Wieland-Alter, Ruth I Connor, Sue Tvaroha, David A Hokey, Ann M Ginsberg, Richard Waddell
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175215 (2017)
Development of a tuberculosis vaccine to boost BCG is a major international health priority. SRL172, an inactivated whole cell booster derived from a non-tuberculous mycobacterium, is the only new vaccine against tuberculosis to have demonstrated eff
Externí odkaz:
https://doaj.org/article/72ed7a4d28b543bb9c08543d05916f7e